Edward Fox
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 13
- Hematology top 1%
- Acute Myeloid Leukemia Research 9
- Molecular Biology top 5%
- DNA Repair Mechanisms 7
- Glycosylation and Glycoproteins Research 7
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research 16
-
- Monoclonal and Polyclonal Antibodies Research 20
-
- Acute Lymphoblastic Leukemia research 9
-
- Immunotherapy and Immune Responses 8
- Co-authors
- Lawrence A. LoebJesse J. SalkScott R. KennedyMichael W. SchmittJoseph B. HiattKate S. Reid-BaylissMarc J. PrindleEun Hyun Ahn
- Journals
- Neurology (16 papers)Blood (11 papers)Proceedings of the National Academy of Sciences (4 papers)
- Partner nations
- United StatesIrelandGermany
In The Last Decade
Edward Fox
92 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Cancer Research 1.3k
- Hematology 646
- Pathology and Forensic Medicine 748
- Molecular Biology 2.1k
- Genetics 321
Countries citing papers authored by Edward Fox
This map shows the geographic impact of Edward Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Fox more than expected).
Fields of papers citing papers by Edward Fox
This network shows the impact of papers produced by Edward Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Fox. The network helps show where Edward Fox may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Edward Fox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 13 | |
| 2 | 2022 | 15 | |
| 3 | 2020 | 1 | |
| 4 | 2015 | 110 | |
| 5 | 2015 | 17 | |
| 6 | 2015 | 28 | |
| 7 | 2015 | 2 | |
| 8 | 2014 | 314 | |
| 9 | 2014 | 10 | |
| 10 | 2014 | 135 | |
| 11 | 2013 | 4 | |
| 12 | Detection of ultra-rare mutations by next-generation sequencingbreakdown → | 2012 | 727 |
| 13 | 2011 | 53 | |
| 14 | 2011 | 38 | |
| 15 | 2010 | 12 | |
| 16 | 2010 | 53 | |
| 17 | 2008 | 41 | |
| 18 | 2006 | 52 | |
| 19 | 2005 | 49 | |
| 20 | Identification and characterization of a novel activating mutation of the FLT3 tyrosine kinase in AML | 2004 | 3 |
About Edward Fox
Edward Fox is a scholar working on Genetics, Hematology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Immunology, having authored 94 papers that have together received 4.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (20 papers), Chronic Lymphocytic Leukemia Research (16 papers), Cancer Genomics and Diagnostics (13 papers), Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (9 papers), Immunotherapy and Immune Responses (8 papers), DNA Repair Mechanisms (7 papers) and Glycosylation and Glycoproteins Research (7 papers). The work is most often cited by research in Cancer Research (1.3k citations), Hematology (646 citations), Pathology and Forensic Medicine (748 citations), Molecular Biology (2.1k citations) and Genetics (321 citations). Edward Fox has collaborated with scholars based in United States, Ireland and Germany. Frequent co-authors include Lawrence A. Loeb, Jesse J. Salk, Scott R. Kennedy, Michael W. Schmitt, Joseph B. Hiatt, Kate S. Reid-Bayliss, Marc J. Prindle, Eun Hyun Ahn, Jacintha O’Sullivan and Jiang-Cheng Shen. Their work appears in journals such as Neurology, Blood, Proceedings of the National Academy of Sciences, The Journal of Immunology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.